COF
60
2
PEP
48
6
TXT
55
3
AAP
24
6
CFG
70
6
ORCL
65
-2
SE
61
-4
JWN
48
6
CF
57
-2
PFE
23
7
WDC
47
4
GE
67
2
HST
49
-9
XRX
44
3
WY
54
4
PRGO
39
3
M
37
12
EL
25
4
LNC
39
3
ES
34
3
COF
60
2
PEP
48
6
TXT
55
3
AAP
24
6
CFG
70
6
ORCL
65
-2
SE
61
-4
JWN
48
6
CF
57
-2
PFE
23
7
WDC
47
4
GE
67
2
HST
49
-9
XRX
44
3
WY
54
4
PRGO
39
3
M
37
12
EL
25
4
LNC
39
3
ES
34
3
Financhill
Back

Inovio Pharmaceuticals 10K Form

Sell
20

INO
Inovio Pharmaceuticals

Last Price:
4.07
Seasonality Move:
18.82%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive INO News And Ratings

See the #1 stock for the next 7 days that we like better than INO

INO Financial Statistics

Sales & Book Value

Annual Sales: $832.01K
Cash Flow: $-27.44M
Price / Cash Flow: 0
Annual Sales: $2.82
Price / Book: 1.44

Profitability

EPS (TTM): -4.47000
Net Income (TTM): $-112.88M
Gross Margin: $0
Return on Equity: 0%
Return on Assets: 0%

Inovio Pharmaceuticals Earnings Forecast

Key Inovio Pharmaceuticals Financial Ratios

  • The Gross Profit Margin over the past 18 years for INO is 0.00%.
  • The Selling, General & Administrative Expenses for INO have been equal to 5,718.93% of Gross Profit Margin.
  • The Research & Development expenses have been 10,417.73% of Revenue.
  • The Interest Expense is -0.90% of Operating Income.
  • The Net Earning history of INO is -16,239.87% of Total Revenues.
  • Per Share Earnings over the last 25 years have been positive in 13 years.

Inovio Pharmaceuticals Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: INO
CUSIP: 45773H
Website: inovio.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

INO Technical Analysis vs Fundamental Analysis

Sell
20
Inovio Pharmaceuticals (INO) is a Sell

Is Inovio Pharmaceuticals a Buy or a Sell?